Search results :

Cabergoline

More information: STITCH, PubChem (stereo-specific compound: 1) and possibly Wikipedia

ATC Codes: G02CB03, N04BC06

Side effects

Options: Show MedDRA Preferred Terms

Side effect Data for drug Placebo Labels
1 2 3 4 5 6 7 8 9 10 11 12
Nausea 16.4% - 43.3% 10.7% - 20% x x x x x x x x x x x x
Headache 3.5% - 26.8% 4.9% - 25% x x x x x x x x x x x x
Dizziness 8.3% - 27% 5% - 10.7% x x x x x x x x x x x x
Constipation 3.8% - 22.7% 0% - 4.1% x x x x x x x x x x x x
Sweating increased 5.2% - 11.1% x
Dyskinesia 3.8% - 16.4% 23% x x x x x x x x x
Influenza 7.1% - 8.2% x
Gastritis 6.7% - 7.6% x x x
Fatigue postmarketing, 4.52% - 7-11% 0% x x x x x x x x x x x x
Hallucination 4.3% - 9% 3.3% x x x x x x x x x
Sleep disorder 5.4% - 7.6% x
Asthenia 3.8% - 8.93% 10% x x x x x x x x x x x
Bronchitis 6.3% - 6.6% x
Back pain 5.7% - 5.8% x
Urinary tract infection 5.7% - 5.8% x
Abdominal pain 5% - 8.23% 5% x x x x x x x x x x x
Hypertension 5.2% x
Leg edema 5.2% x
Dyspepsia 2.38% - 6.93% 0% x x x x x x x x x x x x
Upper respiratory tract infection 4.3% - 5.2% 4.9% x
Euphoric mood 4.7% - 4.8% x
Hypokinesia 4.6% 13.9% x
Nightmare 4.3% x
Pneumonia 4.3% x x
Confusional state 3.3% - 5.8% x x x x x x x x x
Vertigo 1.19% - 4.33% 0% x x x x x x x x x x
Vomiting 2.38% - 7.2% 0% x x x x x x x x x x x x
Arthropathy 3.8% x
Orthostatic hypotension 3.57% - 12.6% 0% - 6.6% x x x x x x x x x x
Prostatic disorder 3.3% x
Depression 2.16% - 3.17% 5% x x x x x x x x
Pain 1.81% - 3.4% x x x x x x x
Diarrhoea 1.81% - 4.3% x x x x x x x x x x
Breast pain 1.19% - 3.46% 0% x x x x x x x x
Paraesthesia 1.19% - 2.6% 0% x x x x x x x x x x x
Dry mouth 0.866% - 10.1% x x x x x x x x x x
Somnolence postmarketing, 2.16% - 18.3% 5% x x x x x x x x x x x x
Nervousness 0.905% - 2.38% 0% x x x x x x x x
Palpitations 1% - 4.8% x x x x x x x x x x x x
Flatulence 1.3% - 2% x x x x x x x x x
Hypotension 1% - 5.5% x x x x x x x x x x
Anorexia 1.3% - 6.7% x x x x x x x x x
Anxiety 1% - 11.1% x x x x x x x x x x
Insomnia 0.866% - 17.3% 9.8% x x x x x x x x x
Syncope postmarketing, 1% - 1.36% x x x x x x x x x x x x
Hot flush 1.19% - 2.71% 5% x x x x x x x x x x x
Dysmenorrhoea 0.905% - 1.19% 0% x x x x x x x x
Oedema peripheral 0.905% - 8.5% x x x x x x x x x
Pruritus 0.905% - 1% x x x x x x x x
Gravitational oedema 0.905% - 1% x x x x x x x x
Arthralgia 0% - 6.7% x x x x x x x x x
Rhinitis 1% - 3.9% x x x x x x x x x
Cerebration impaired 1% x x x x x x x x x
Abnormal vision 0.866% - 1.19% 0% x x x x x x x x
Periorbital oedema 0.866% - 0.905% x x x x x x x x
Acne 0% - 1.36% x x x x x x x x
Toothache 0% - 0.905% x x x x x x x x
Malaise 0% - 0.905% x x x x x x x x
Influenza-like symptoms 0% - 0.905% x x x x x x x x
Throat irritation 0% - 0.905% x x x x x x x x
Aggression postmarketing x x x x x x x x x
Alopecia postmarketing x x x x x x x x x x
Delusion postmarketing x x x x x
Dyspnoea postmarketing, 3.3% x x x x x
Oedema postmarketing x x x x x
Rash postmarketing x x x x x
Fibrosis postmarketing x x x x x x x x x x
Cardiac valve disease postmarketing x x x x x x x x x x x x
Hypersensitivity postmarketing x x x x x
Impulse-control disorder postmarketing x x
Libido increased postmarketing x x x x x x x x x x x
Cramps of lower extremities postmarketing x x x
Pathological gambling postmarketing x x x x x x x x
Pericardial effusion postmarketing x x x
Pericarditis postmarketing x x x
Pleural effusion postmarketing x x x x x x x x x x x x
Pleurisy postmarketing x x x
Psychotic disorder postmarketing x x x x x x x x x
Pulmonary fibrosis postmarketing x x x x x x x x x x x x
Retroperitoneal fibrosis postmarketing x x x
Vasospasm postmarketing x x x
Hepatic function abnormal postmarketing x x x x
Liver function test abnormal postmarketing x x x x x
Blood creatinine increased postmarketing x
Hypersexuality postmarketing x x x x x x x x
Excessive daytime sleepiness postmarketing x
Respiratory failure postmarketing x x x x x
Regurgitation postmarketing x x x x
Pleural fibrosis postmarketing x x x
Congenital anomaly x
Arrhythmia x
Neoplasm malignant x
Duodenal ulcer x x x x x x x x
Epistaxis x x x x x x x x x x
Cardiac disorder x
Cardiac failure x x x x x x x x
Hemianopia x x x x
Musculoskeletal pain x x x
Nasal congestion x x x x x x x x
Pericarditis constrictive x x x x x x x x
Congenital genitourinary abnormality x
Weight increased x x x x x x x x
Weight decreased x x x x x x x x
Lightheadedness x
Epigastric pain x x x x
Upset stomach x
Face oedema x x x x x x x x
Breast pain female x x x
Hypotensive x x x
Hypotension symptomatic x x
Sudden onset of sleep x

Indications

Information about indications was extracted from the indications and usage sections of the labels.

Cabergoline

Side effects:32
Source:BC Cancer

The active ingredient in Dostinex is cabergoline / DOSTINEX

Side effects:49
Source:medicines.org.au

Cabergoline tablet / Dostinex, Tablet

Side effects:49
Source:Medsafe

CABERGOLINE

Side effects:61
Source:FDA Structured Product Label

cabergoline

Side effects:62
Source:FDA Structured Product Label

CABERGOLINE

Side effects:62
Source:FDA Structured Product Label

CABERGOLINE / DOSTINEX

Side effects:57
Source:FDA

CABERGOLINE / DOSTINEX

Side effects:60
Source:FDA

CABERGOLINE / DOSTINEX

Side effects:62
Source:FDA

CABERGOLINE / CO CABERGOLINE

Side effects:70
Source:Health Canada

CABERGOLINE / DOSTINEX

Side effects:74
Source:Health Canada

Color scheme:

standard – alternative

    100%
    75%
    50%
    10%
    frequent (1% to 100%)
    infrequent (0.1% to 1%)
    rare (<0.1%)
    postmarketing
    0%
    no frequency information
    not found on label